News

Benefits of Lifestyle Intervention Only Brief in Some T2DM Patients

Author and Disclosure Information

 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

References

No changes were observed in blood pressure, weight, or physical activity over the course of 12 months in either group.

Although LIFE lacked a third study arm that received usual care, one possible implication of the current findings “may be that diabetes education of any type may be helpful in improving glycemic control, especially in a population that does not normally receive any education,” she said. “Medication adherence may be an easier and more effective strategy to improve glycemic control in this population.”

LIFE was supported by grants from the National Institutes of Health. Dr. Lynch reported having no relevant financial disclosures.

Pages

Recommended Reading

FDA strengthens kidney warnings on two diabetes drugs
Type 2 Diabetes ICYMI
Empagliflozin slows renal disease progression in type 2 diabetes
Type 2 Diabetes ICYMI
Pioglitazone safe and effective for steatohepatitis in T2DM
Type 2 Diabetes ICYMI
FDA Strengthens Kidney Warnings on Two Diabetes Drugs
Type 2 Diabetes ICYMI
Study Plots Long-term Financial Impact of Diabetes
Type 2 Diabetes ICYMI
Artificial pancreas can improve inpatient glycemic control in type 2 diabetes
Type 2 Diabetes ICYMI
LEADER: Liraglutide lowers CVD risk in type 2 diabetes
Type 2 Diabetes ICYMI
Long-term metformin use protective against neurodegenerative disease
Type 2 Diabetes ICYMI
SDPI Reports to Congress: Seeing Successes
Type 2 Diabetes ICYMI
Long-term Metformin Use Protective Against Neurodegenerative Disease
Type 2 Diabetes ICYMI